Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Candiani, G.
Right arrow Articles by Williams, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Candiani, G.
Right arrow Articles by Williams, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy, Vol 39, 199-207, Copyright © 1997 by The British Society for Antimicrobial Chemotherapy


JOURNAL ARTICLE

Experimental lobar pneumonia due to penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae in immunocompetent and neutropenic rats: efficacy of penicillin and teicoplanin treatment

G Candiani, M Abbondi, M Borgonovi and R Williams
Lepetit Research Center, Hoechst Marion Roussel, Gerenzano (Varese), Italy.

Lobar pneumonia models were established in rats by intratracheal inoculation of either penicillin-susceptible (immunocompetent model) or penicillin-resistant (immunocompetent and neutropenic models) Streptococcus pneumoniae. Untreated animals maintained a relatively high bacterial load in the lungs but only occasionally developed bacteraemia or pleurisy. The infection was rarely fatal in immunocompetent rats, but immunocompromised rats frequently died. Treatment i.m. with 10,000 IU/kg of procaine penicillin G (12 h after infection then bid for 3 days) or with a single i.v. dose of 5 or 10 mg/kg of teicoplanin significantly reduced lung bacterial loads of rats infected with the penicillin-susceptible strain. Against the penicillin- resistant strain, teicoplanin displayed a significant activity regardless of the immununological status of the animals. Penicillin G significantly reduced lung bacterial load of the penicillin-resistant strain only in immunocompetent rats and at a higher dose than needed in treatment of the penicillin-susceptible infection. The experimental models described here could be suitable for studying the efficacy of antibacterial agents against pulmonary infections caused by penicillin- susceptible and penicillin-resistant S. pneumoniae strains.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
D. Chiavolini, G. Pozzi, and S. Ricci
Animal Models of Streptococcus pneumoniae Disease
Clin. Microbiol. Rev., October 1, 2008; 21(4): 666 - 685.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. Prass, J. S. Braun, U. Dirnagl, C. Meisel, and A. Meisel
Stroke Propagates Bacterial Aspiration to Pneumonia in a Model of Cerebral Ischemia
Stroke, October 1, 2006; 37(10): 2607 - 2612.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
L. Piroth, L. Martin, A. Coulon, C. Lequeu, M. Duong, M. Buisson, H. Portier, and P. Chavanet
Development of a New Experimental Model of Penicillin-Resistant Streptococcus pneumoniae Pneumonia and Amoxicillin Treatment by Reproducing Human Pharmacokinetics
Antimicrob. Agents Chemother., October 1, 1999; 43(10): 2484 - 2492.
[Abstract] [Full Text]


Home page
J Antimicrob ChemotherHome page
G. Candiani, M. Abbondi, M. Borgonovi, G. Romano, and F. Parenti
In-vitro and in-vivo antibacterial activity of BI 397, a new semi-synthetic glycopeptide antibiotic
J. Antimicrob. Chemother., August 1, 1999; 44(2): 179 - 192.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.